×

Mad Money tweets

6:45 PM ET Fri, 27 Sept 2013

Nektar fell 24 percent today after it announced its critical trial of a drug for chronic pain missed its primary endpoint. Mad Money viewers ask Jim Cramer their investment questions via Twitter.